The major ECM constituent, hyaluronic acid (HA), was found to be increased in IPF patients [10, 11], and its ability to promote transforming growth factor beta 1- (TGFβ1-) mediated fibroblast proliferation [3] led to IPF pathogenesis. The gene discussed is TGFB1; the disease is idiopathic pulmonary fibrosis.